ArticlePharmacoEconomics - open2025

Treatment (as Prevention) Availability and Individuals' Behavior: A Cost-Effectiveness Analysis of Cabotegravir Long-Acting Injectable PrEP.

J Felipe Montano-Campos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.